title: Embryonal rhabdomyosarcoma of the uterine corpus.
authors.affiliation: Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
authors.forename: Leslie A
authors.initials: LA
authors.lastname: Garrett
authors.forename: David C
authors.initials: DC
authors.lastname: Harmon
authors.forename: John O
authors.initials: JO
authors.lastname: Schorge
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D010535:Laparoscopy; D008197:Lymph Node Excision; D008279:Magnetic Resonance Imaging; D008796:Metrorrhagia / Q000209:etiology*; D009361:Neoplasm Invasiveness; D011127:Polyps / Q000175:diagnosis; D018233:Rhabdomyosarcoma, Embryonal / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014594:Uterine Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide